Special Feature

User Panel

My Panel

My Panel

Bookmark Science Articles

Recent News
Bookmark / Share This Science Site

[Role of TJU103 in prevention of graft-versus-host disease after allogeneic stem cell transplantation in mice]

[Role of TJU103 in prevention of graft-versus-host disease after allogeneic stem cell transplantation in mice] Research Abstract Details 

Research Abstract Table of Contents

Jump to the:

  • Abstract Text of This Paper
  • Journal Published
  • MeSH Keywords of This Abstract
  • Chemicals and Substances Used in this Paper
  • Grants and Granting Agency of this Research
  • Database Accession Numbers Used in this Paper
  • Related Papers
  • Related Research Tags
  • Rate this Research Paper
  • [Role of TJU103 in prevention of graft-versus-host disease after allogeneic stem cell transplantation in mice] Abstract Text:

    san-bin wangSan-bin Wang,kun-yuan guoKun-yuan Guo,deng-ming huDeng-ming Hu,bo yinBo Yin,

    OBJECTIVE: To explore the role of TJU103 in preventing graft-versus-host disease (GVHD) after allogeneic stem cell transplantation in mice. METHODS: BALB/c mouse splenic lymphocytes were collected and treated by mitomycin as the activating cells and the C57BL/6 mouse splenic lymphocytes as the reacting cells. In the experimental groups, the effect of TJU103 on the proliferative response of T cells was observed. BALB/c(H-2d) and CB6F1(H-2d/b) mice were used as the MHC-full-mismatched recipients and MHC-haplo-identical recipients, respectively, and pretreated by total body irradiation at 9.0 Gy before transplantation. For the recipients of the irradiation group, 0.3 ml D-Hank's solution was injected through the tail vein without cell transplantation, the recipients of the control group received injection of 4.5x10(6) bone marrow cells mixed with 3.0x10(7) spleen cells from C57BL/6 mice through the tail vein, and those in the experimental group received cell transplantation in the same manner with also injection via the tail vein of 25 microg/ml TJU103, which was subsequently injected intraperitoneally for 7 consecutive days at daily dose of 50 microg. The hematopoietic recovery, engraftment and GVHD of the recipients were observed. RESULTS: TJU103 resulted in a dose-dependent inhibition of T cell proliferation in mixed lymphocyte reaction (MLR), and nearly 83% inhibition of the proliferative response was observed with the addition of 25 microg/ml of TJU103. Without any treatment, the occurrence of GVHD and death rate in the control group was both 10/10. Daily injection of TJU103 at 50 microg for the initial post-transplantation week protected the mice from GVHD. In the MHC-full-mismatched model, the incidence of GVHD and survival rate on day 30 of the experiment group was 2/10 and 8/10, showing significant difference from those in the control group (P<0.01). The median survival time (MST) was 30 days in the experimental group versus 15 days in the control group (P<0.05). In the MHC-haplo-identical model, the incidence of GVHD and the survival rate on day 30 of the experimental group was 1/10 and 9/10, which were significantly different from the control group (P<0.01). The MST was 30 days in the experimental group versus 14 days in the control group (P<0.05). CONCLUSION: TJU103 is capable of markedly inhibiting T cell proliferative response in vitro and can decrease GVHD incidence after allogeneic stem cell transplantation in mice.

    [Role of TJU103 in prevention of graft-versus-host disease after allogeneic stem cell transplantation in mice] Publishing Authors By Initials

    sb wangSB Wang,ky guoKY Guo,dm huDM Hu,b yinB Yin,

    For similar abstracts research abstracts see: abstracts research

    PUBMED ID PMID:

    MEDLINE DATE:

    [Role of TJU103 in prevention of graft-versus-host disease after allogeneic stem cell transplantation in mice] Journal Published:

    PUBLICATION TYPE: Journal Article

    Journal: Nan fang yi ke da xue xue bao = Journal of Souther

    VOLUME: 26

    Page Numbers: 810-3

    Journal Abbreviation: Nan Fang Yi Ke Da Xue Xue Bao

    ISSN: 1673-4254

    DAY: 23

    MONTH: Jun

    YEAR: 2006

    [Role of TJU103 in prevention of graft-versus-host disease after allogeneic stem cell transplantation in mice] Information

    Number of References:

    LANGUAGE: chi

    NlmUniqueID: 101266132

    [Role of TJU103 in prevention of graft-versus-host disease after allogeneic stem cell transplantation in mice] Keywords Mesh Terms:

    KEYWORDS:

    MESH TERMS:

    Chemical & Substance for Abstract: [Role of TJU103 in prevention of graft-versus-host disease after allogeneic stem cell transplantation in mice] Information

    Substance Name:

    Registry Number:

    Grant and Affiliation Information for [Role of TJU103 in prevention of graft-versus-host disease after allogeneic stem cell transplantation in mice]

    AFFILIATION: Department of Hematology, Kunming General Hospital of Chengdu Command, Kunming 650032, China. wangsanbinlili@163.net

    Country: China

    China Research PublicationChina Research Publication

    AGENCY:

    GRANT:

    ACRONYM:

    MEDLINETA: Nan Fang Yi Ke Da Xue Xue Bao

    REFSOURCE:

    DATABASENAME:

    ACCESSION NUMBER:

    Number Hits: 0

    Role of TJU103 in prevention of graft-versus-host disease after allogeneic stem cell transplantation in mice Related Publications

     

    Molecular Station USER Menu

    Welcome to Molecular Station!

    You have to register before you can post on our forums or use our advanced features. Register Now! Its Free and Fast!

    Already registered? Login now below.

    User Name:

    Password:

    Already registered and Forgot your password? Click below to recover it.

    Recover Lost Password

    Join now - it's fast and free!

    Molecular Station is THE largest network of researchers, scientists and science lovers anywhere!

    Research Terms of Usage and Disclaimer
    Home
    Features

    Protocols

    DNA Forum

    Science Forum

    DNA Forum
    Biology Forum

    Science News


    [CaRP] XML error: Invalid document end at line 2

    For more click here:Science News